Steven Yates

发表

Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.

Michael J Schell, Martha Moore, Ji-Hyun Lee, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second‐line, low‐dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first‐line chemotherapy with carboplatin plus paclitaxel

M. Socinski, A. Peterman, M. Schell, 2002, Cancer.